Potentiating effects of GHRH analogs on the response to chemotherapy.

about

New therapeutic approach to heart failure due to myocardial infarction based on targeting growth hormone-releasing hormone receptor.Magnetoelectric nanoparticles for delivery of antitumor peptides into glioblastoma cells by magnetic fields.

P2860

Q35833122-7B4138DF-3330-4E9C-A13E-E8FBC1EB44C1 Q47652837-77E5BFAF-B345-4FA6-A532-1723D609BC9B

P2860

Potentiating effects of GHRH analogs on the response to chemotherapy.

Item

http://www.wikidata.org/entity/Q35565027

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Potentiating effects of GHRH analogs on the response to chemotherapy.

@ast

Potentiating effects of GHRH analogs on the response to chemotherapy.

@en

type

Item

label

Potentiating effects of GHRH analogs on the response to chemotherapy.

@ast

Potentiating effects of GHRH analogs on the response to chemotherapy.

@en

prefLabel

Potentiating effects of GHRH analogs on the response to chemotherapy.

@ast

Potentiating effects of GHRH analogs on the response to chemotherapy.

@en

P1476

Potentiating effects of GHRH analogs on the response to chemotherapy.

@en

P2093

Ferenc G Rick

http://www.w3.org/2001/XMLSchema#string

Norman L Block

http://www.w3.org/2001/XMLSchema#string

Roberto Perez

http://www.w3.org/2001/XMLSchema#string

P2860

Inflammation and cancer

Targeted cytotoxic analog of luteinizing hormone-releasing hormone (LHRH), AEZS-108 (AN-152), inhibits the growth of DU-145 human castration-resistant prostate cancer in vivo and in vitro through elevating p21 and ROS levels.

Proinflammatory cytokines enhance estrogen-dependent expression of the multidrug transporter gene ABCG2 through estrogen receptor and NF{kappa}B cooperativity at adjacent response elements.

Mechanisms of synergism between antagonists of growth hormone-releasing hormone and antagonists of luteinizing hormone-releasing hormone in shrinking experimental benign prostatic hyperplasia.

Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.

Antagonists of growth hormone-releasing hormone (GHRH) reduce prostate size in experimental benign prostatic hyperplasia

Antagonistic analogs of growth hormone-releasing hormone increase the efficacy of treatment of triple negative breast cancer in nude mice with doxorubicin; A preclinical study

Triple negative breast cancers express receptors for LHRH and are potential therapeutic targets for cytotoxic LHRH-analogs, AEZS 108 and AEZS 125

Inflammatory mediators in breast cancer: coordinated expression of TNFα & IL-1β with CCL2 & CCL5 and effects on epithelial-to-mesenchymal transition

Synergistic inhibition of growth of lung carcinomas by antagonists of growth hormone-releasing hormone in combination with docetaxel

P304

699-704

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1080/15384101.2015.1010893

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Andrew Schally

P577

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272081717

http://www.w3.org/2001/XMLSchema#string

P698

25648497

http://www.w3.org/2001/XMLSchema#string

P921

chemotherapy

P932

4418275

http://www.w3.org/2001/XMLSchema#string

Potentiating effects of GHRH analogs on the response to chemotherapy.

about

P2860

P2860

Potentiating effects of GHRH analogs on the response to chemotherapy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P921

P932